See every side of every news story
Published loading...Updated

Iambic and Revolution Medicines Partner on AI Cancer Drug Discovery

Revolution Medicines, a late-stage clinical oncology company, and Iambic Therapeutics, an AI-driven drug discovery company, have announced a multi-year technology and research collaboration to pursue novel drug candidates using Iambic’s AI models.   Iambic will use Revolution Medicine’s structures and molecular libraries to train a bespoke version of NeuralPLexer, Iambic’s AI model for protein-ligand structure prediction.  Both companies will ha…

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Wednesday, July 9, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.